Persistent pain after surgery for cutaneous melanoma

Clinical Journal of Pain

Volumn 28, Issue 2, 2012, Pages 149-156

  Høimyr, Hilde ^a   Von Sperling, Marie Louise ^a   Rokkones, Kristina Asdahl ^a   Stubhaug, Audun ^b   Finnerup, Kenneth ^a   Jensen, Troels Staehelin ^c   Finnerup, Nanna Brix ^c  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

clinical examination; melanoma; pain; questionnaire; sensory disturbance

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; FENTANYL; INTERFERON; INTERLEUKIN 2; LIDOCAINE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROPOFOL; REMIFENTANIL; SEVOFLURANE; TEMOZOLOMIDE; TRAMADOL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER SURVIVOR; CHRONIC PAIN; CLINICAL EXAMINATION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DYSESTHESIA; EXCISION; FEMALE; FOLLOW UP; GENERAL ANESTHESIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEUROPATHIC PAIN; PAIN ASSESSMENT; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUESTIONNAIRE; SCAR; SENSORY DYSFUNCTION; SKIN GRAFT;

CHRONIC PAIN; COMORBIDITY; DENMARK; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; PAIN, POSTOPERATIVE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84855822127     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e31822a6887     Document Type: Article

References (36)

1. Gupta A, Mehdi A, Duwell M, et al. Evidence-based review of the pharmacoeconomics related to the management of chronic nonmalignant pain. J Pain Palliat Care Pharmacother. 2010; 24:152-156.
2. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367:1618-1625. (Pubitemid 43674227)
3. The National Board of Health, Denmark. Available at http://www.sst.dk/ English.aspx. Assessed January 10, 2011.
4. Markovic SN, Erickson LA, Rao RD, et al.Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007;82:364-380. (Pubitemid 46348938)
5. Markovic SN, Erickson LA, Rao RD, et al. Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc. 2007;82:490-513. (Pubitemid 46543475)
6. Gotoda Y, Kambara N, Sakai T, et al. The morbidity, time course and predictive factors for persistent post-thoracotomy pain. Eur J Pain. 2001;5:89-96. (Pubitemid 32661931)
7. Jung BF, Ahrendt GM, Oaklander AL, et al. Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain. 2003;104:1-13. (Pubitemid 36835869)
8. Katz J, Poleshuck EL, Andrus CH, et al. Risk factors for acute pain and its persistence following breast cancer surgery. Pain. 2005;119:16-25. (Pubitemid 41752961)
9. Aasvang EK, Gmaehle E, Hansen JB, et al. Predictive risk factors for persistent postherniotomy pain. Anesthesiology. 2010;112:957-969.
10. Danish Melanoma Group, Danish. Available at http://www.melanoma.dk/ Assessed January 10, 2011.
11. Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114:29-36. (Pubitemid 40279084)
12. Bouhassira D, Lanteri-Minet M, Attal N, et al. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008;136:380-387. (Pubitemid 351680253)
13. Sullivan MJL, Bishop S, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess. 1995;7:524-532. (Pubitemid 26017352)
14. Ware JE, Snow KK, Kosinski M, et al. SF-36 Health Survey: Manual and Interpretation Guide. Boston: The Health Institute; 1993.
15. Bj̈rner JB, Damsgaard MT, Watt T. Danish Report from 1997 provided by Lif/The Danish Association of the Pharmaceutical Industry, www.lifdk.dk. Danish manual for the use of SF-36.
16. Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain. 2004;108:248-257. (Pubitemid 38353047)
17. Kroner K, Knudsen UB, Lundby L, et al. Long-term phantom breast syndrome after mastectomy. Clin J Pain. 1992;8:346-350. (Pubitemid 23039035)
18. Gartner R, Jensen MB, Nielsen J, et al. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009;302:1985-1992.
19. Sperling ML, Hoimyr H, Finnerup K, et al. Persistent pain and sensory changes following cosmetic breast augmentation. Eur J Pain. 2010;15:328-332.
20. Wildgaard K, Ravn J, Nikolajsen L, et al. Consequences of persistent pain after lung cancer surgery: a nationwide questionnaire study. Acta Anaesthesiol Scand. 2011;55:60-68.
21. Nikolajsen L, Ilkjaer S, Christensen JH, et al. Pain after amputation. Br J Anaesth. 1998;81:486.
22. Nikolajsen L, Staehelin JT. Phantom limb pain. Curr Rev Pain. 2000;4:166-170.
23. Gottrup H, Bach FW, Juhl G, et al. Differential effect of ketamine and lidocaine on spontaneous and mechanical evoked pain in patients with nerve injury pain. Anesthesiology. 2006;104:527-536.
24. Jensen TS, Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain. 2003;102:1-8. (Pubitemid 36298856)
25. Jensen TS, Kehlet H. Pain following thoracotomy: is it neuropathic? Pain. 2011;152:12-13.
26. Nikolajsen L, Ilkjaer S, Kroner K, et al. The influence of preamputation pain on postamputation stump and phantom pain. Pain. 1997;72:393-405. (Pubitemid 27392856)
27. Wildgaard K, Iversen M, Kehlet H. Chronic pain after lung transplantation: a nationwide study. Clin J Pain. 2010; 26:217-222.
28. Aasvang EK, Brandsborg B, Jensen TS, et al. Heterogeneous sensory processing in persistent postherniotomy pain. Pain. 2010;150:237-242.
29. Finnerup NB, Jensen TS. Mechanisms of disease: mechanismbased classification of neuropathic pain-a critical analysis. Nat Clin Pract Neurol. 2006;2:107-115. (Pubitemid 43210251)
30. Fujita M, Andoh T, Ohashi K, et al. Roles of kinin B1 and B2 receptors in skin cancer pain produced by orthotopic melanoma inoculation in mice. Eur J Pain. 2010;14:588-594.
31. Vase L, Nikolajsen L, Christensen B, et al. Cognitiveemotional sensitization contributes to wind-up-like pain in phantom limb pain patients. Pain. 2011;152:157-162.
32. Aasvang E, Kehlet H. Chronic postoperative pain: the case of inguinal herniorrhaphy. Br J Anaesth. 2005;95:69-76. (Pubitemid 40903888)
33. Poobalan AS, Bruce J, Smith WC, et al. A review of chronic pain after inguinal herniorrhaphy. Clin J Pain. 2003;19: 48-54. (Pubitemid 36043450)
34. Maguire MF, Ravenscroft A, Beggs D, et al. A questionnaire study investigating the prevalence of the neuropathic component of chronic pain after thoracic surgery. Eur J Cardiothroac Surg. 2006;29:800-805.
35. Cruccu G, Sommer C, Anand P, et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol. 2010;17:1010-1018.
36. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1664-1678. (Pubitemid 28465486)